NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • Welcome Guide
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Case Studies
    • Patient and Public Involvement and Engagement (PPIE) Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
    • Public events
    • Patient & Public Involvement events
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Digital Health from Hospital to Home > Study challenges idea of clinically significant mid-pregnancy drop in blood pressure

Study challenges idea of clinically significant mid-pregnancy drop in blood pressure

28 April 2021 · Listed under Digital Health from Hospital to Home

An international study involving NIHR Oxford BRC researchers has shown where normal blood pressure in pregnancy should be across the world and when clinicians should react because it is abnormal.

Photo by freestocks on Unsplash

The study’s findings, published in PLOS Medicine, provide international, gestational age-specific centiles and limits of acceptable change to facilitate earlier recognition of deteriorating health in pregnant women.

“These centiles challenge the idea of a clinically significant mid-pregnancy drop in blood pressure,” said one of the authors, Prof Peter Watkinson, joint clinical lead for the Critical Care Research Group at the University of Oxford’s Nuffield Department of Clinical Neurosciences.

“We hope this international study will help to improve diagnosis of illnesses affecting blood pressure in pregnancy,” said Prof Watkinson, the Oxford BRC’s Joint Theme Lead for Technology and Digital Health.

The purpose of the study was to identify internationally applicable gestational age-specific centiles for blood pressure in clinical practice to determine when women have left the ‘normal’ range.

As part of the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Project, the research team recruited 4,607 healthy women across eight countries: Brazil, China, India, Italy, Kenya, Oman, the United Kingdom and the United States.

The researchers found that, on average, systolic blood pressure rose by around 8 mmHg (millimetres of mercury, the standard measurement for blood pressure) between 12 and 40 weeks’ gestation, with no decrease in mid-pregnancy. Diastolic blood pressure decreased slightly between 12 and 19 weeks, rising thereafter until 40 weeks’ gestation.

At any gestational age, systolic blood pressure fell by more than 14 mmHg and diastolic blood pressure by more than 11 mmHg from baseline in fewer than 10% of women. Fewer than 10% of women increased their systolic blood pressure by more than 24 mmHg or diastolic blood pressure by more than 18 mmHg at any gestational age.

← Oxford academics named NIHR Senior Investigators
Oxford wins government funding to evaluate prostate cancer detection system →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre